Aprea Therapeutics, Inc. (APRE)
1.01
+0.01
(+1.00%)
USD |
NASDAQ |
Apr 20, 12:45
Aprea Therapeutics SG&A Expense (Quarterly) : 1.638M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Modular Medical, Inc. | 1.839M |
| Ernexa Therapeutics, Inc. | 1.418M |
| Recursion Pharmaceuticals, Inc. | 33.66M |
| Tango Therapeutics, Inc. | 9.763M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |